Monday, June 15, 2026

A New Champion Emerges: Chris Gotterup’s First PGA Tour Triumph

Professional golfer Chris Gotterup from the United...

Reddit Sues AI Startup for Stealing User Data—Here’s What Happened

Reddit sues AI startup Anthropic for breaching contract by harvesting user data without consent to train AI models, seeking damages.

North Korean Plane Lands in Shanghai — Could Regular Flights Be Next?

North Korea's Air Koryo resumes flights to Shanghai, hinting at a potential revival of the Pyongyang-Shanghai route post-pandemic.

Tag: SK Biopharmaceuticals

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

SK Biofarm, FDA Approved Radioactive Method: Will it be a Revolutionary Cancer Cure with SLK 33501?

SK Biopharmaceuticals gains FDA approval for Phase 1 trials of radiopharmaceuticals SKL35501 and SKL35502, advancing cancer treatment.

Top News

- Our Sponsors Ad -

Follow us